Group Therapy for Postpartum Depression
|ClinicalTrials.gov Identifier: NCT00051246|
Recruitment Status : Completed
First Posted : January 8, 2003
Last Update Posted : January 24, 2014
|Condition or disease||Intervention/treatment|
|Depression, Postpartum||Behavioral: Mother-Infant Group Psychotherapy Behavioral: Interpersonal Psychotherapy|
Ten to twenty percent of new mothers experience major depression in the postpartum period or postpartum depression (PPD). This condition poses a risk for disturbances in the mother-infant relationship as well as for developmental delays and subsequent psychopathology in their children. Thus, and investigation of the efficacy of a relational approach that focuses on improving the mother's sense of competence in the parenting role, and reducing depressive symptoms and social isolation through group therapy is warranted.
Patients are randomly assigned to either relational group treatment or to standard individual treatment. Assessments of maternal and infant functioning, mother-infant and father-infant relations, parenting stress, and marital conflict and conducted pre- and post-treatment, at 12 months post-treatment, and when infants are 12 and 24 months of age.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||147 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Relational Group Intervention for Postpartum Depression|
|Study Start Date :||January 2002|
|Primary Completion Date :||July 2008|
|Study Completion Date :||July 2008|
Active Comparator: 1 M-ITG
Mother-infant group psychotherapy
Behavioral: Mother-Infant Group Psychotherapy
Mother-infant group psychotherapy consists of weekly 2.5-hour psychotherapy sessions comprised of mother's group therapy, infant developmental therapy, and mother-infant dyadic psychotherapy. Group treatment will last 15 weeks.
Active Comparator: 2 - IPT
Individual interpersonal psychotherapy
Behavioral: Interpersonal Psychotherapy
Individual psychotherapy treatment focuses on role transition, interpersonal relationships, and loss. Individual treatment period will last 15 weeks.
- Reduction of depression as measured by the Hamilton Rating Scale for Depression (HRSD) [ Time Frame: Measured at post-treatment and Month 12 follow-up ]
- Improvement in parent-infant interactions as measured by the Early Relational Assessment (ERA) [ Time Frame: Measured at post-treatment, Month 12 follow-up, and 12 and 24 months of age ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00051246
|United States, Wisconsin|
|University of Wisconsin Dept. of Psychiatry|
|Madison, Wisconsin, United States, 53719|
|Principal Investigator:||Roseanne Clark, PhD||University of Wisconsin, Madison|